Answer
Otigo ear drops require particular caution in patients susceptible to methaemoglobinaemia, including infants under 3 months and patients with haemoglobinopathies or glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Sources for this answer
- Otigo 40 mg/10 mg/g ear drops, solutionRenascience Pharma Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked